It was found that FSH supplementation reversed induced tumor inhibition, both prophylactically (Degarelix and FSH therapy were initiated after cell inoculation) and therapeutically (therapy was initiated 3 weeks after cell inoculation) (Oduwole et al., 2021). Here, BRD2 is linked to neoplasm.